Please use this identifier to cite or link to this item:
Title: Renal osteodystrophy in Ramathibodi Hospital : Histomorphometry and clinical correlation
Authors: Changsirikulchai S.
Sirikulchayanonta V.
Kunkitti N.
Radienahamed P.
Domrongkitchaiporn S.
Ongphiphadhanakul B.
Stitchantrakul W.
Keywords: adult
bone density
chronic kidney failure
clinical trial
comparative study
middle aged
photon absorptiometry
prospective study
renal osteodystrophy
renal replacement therapy
risk assessment
statistical model
Absorptiometry, Photon
Bone Density
Hospitals, Urban
Kidney Failure, Chronic
Logistic Models
Middle Aged
Prospective Studies
Renal Dialysis
Renal Osteodystrophy
Risk Assessment
Issue Date: 2000
Abstract: The spectrum and clinical relevance of renal osteodystrophy in Thai dialysis patients are unknown. A study was conducted on the prevalence and clinico-pathological correlation of renal osteodystrophy in chronic dialysis patients who attended Ramathibodi Renal Transplant Clinic between September 1996 and March 1998. All possible volunteers were enrolled irrespective of musculoskeletal symptoms. Fifty six dialysis patients, including 17 (30.4%) CAPD and 39 (69.6%) hemodialysis patients, participated in this study. Serum calcium, phosphate, iPTH, and bone specific alkaline phosphatase were determined. Transiliac crest bone specimens were measured with an average of 30 fields/specimen by a specific computer program for bone histomorphometry (Osteomeasure), and were also studied for dynamic by double tetracycline label. Bone mineral density (BMD) was also determined by DEXA scan. The type of bone pathology was based on Fournier's criteria for renal osteodystrophy. The mean±SEM for age was 45.52± 1.74 years, dialysis duration 42.26±5.54 (range 1-156) months, calcium phosphate product 52.31±2.77, and iPTH 307.73±62.04 pg/ml. The following types of renal osteodystrophy were found: adynamic bone 23 (41.1%), hyperparathyroid 16 (28.6%), mixed type 11 (19.6%), mild lesion 3 (5.4%), osteomalacia 2 (3.6%), and osteosclerosis 1 (1.8%) cases. Two cases of aluminum related bone disease were found. The distribution of different bone diseases was not affected by mode of dialysis or vitamin D supplement, but it was affected by dialysis duration. High turnover bone diseases were associated with longer dialysis duration (63.19±8.9 vs 23±4.73 months), higher iPTH (541.53±109.32 vs 87.77±15.76 pg/ml), and higher bone specific alkaline phosphatase (25.43±5.04 vs 9.62±1.34 mg/ml) when compared to low turnover bone diseases, p < 0.05. Intact PTH of greater than 200 pg/ml was a good predictor for high turnover bone diseases (74% sensitivity and 96% specificity). BMD at torch and wards areas varied inversely with dialysis duration (r = -0.3 and r= -0.4, respectively; p < 0.05). Chronic dialysis patients had a greater tendency of bone loss compared to the general Thai population. There was no difference in BMD between CAPD and hemodialysis patients or different types of bone lesions. Conclusion: Significant bone diseases are common among Thai chronic dialysis patients. Adynamic bone disease is the most common bone lesion followed by hyperparathyroid and mixed type. The spectrum of bone diseases is affected mainly by dialysis duration. Intact PTH is a good predictor of high turnover bone disease. Greater bone loss than in the general population is common in our patients and is also accentuated by longer dialysis duration.
ISSN: 1252208
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.

Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.